Report Description Table of Contents Glucosinolates Market Size, Share, Volume, Growth & Forecast, 2026–2032 The Global Glucosinolates Market was valued at approximately USD 112.0 million in 2025 and is projected to reach around USD 194.4 million by 2032, expanding at a CAGR of approximately 8.2% during 2026–2032. Commercial sales reached approximately 780 metric tonnes in 2025, representing an average revenue realization of nearly USD 143 per kg across standardized extracts, glucosinolate-rich specialty ingredients and high-purity compounds. Commercial volume is projected to approach 1,290 metric tonnes by 2032, supported by expanding demand for standardized glucoraphanin, sinigrin and other Brassicaceae-derived functional ingredients. Glucosinolates are sulfur-containing phytochemicals naturally concentrated in broccoli, mustard, kale, cabbage, radish, watercress, rapeseed and related Brassicaceae plants. Their commercial importance comes from the interaction between glucosinolates and the enzyme myrosinase, which forms biologically active isothiocyanates. Glucoraphanin converts to sulforaphane, while sinigrin generates allyl isothiocyanate, creating commercially valuable pathways for nutraceuticals, functional nutrition, biomedical research, agriculture and specialty food applications. Commercial glucosinolate demand increasingly centers on standardized active content. Broccoli extracts are now offered at glucoraphanin concentrations ranging from below 1% to 30%, while mustard extracts can reach 25% glucosinolate. Ingredient buyers consequently evaluate botanical origin, HPLC assay, stability, myrosinase compatibility, dosage efficiency and batch consistency alongside conventional price-per-kilogram considerations. Current commercial broccoli seed products are commonly supplied in 25 kg drums, illustrating the transition of glucosinolates from plant phytochemistry into a defined international ingredient category. Glucoraphanin Generates the Largest Share of Commercial Value Glucoraphanin accounted for approximately 58.5% of global Glucosinolates Market revenue in 2025, generating nearly USD 65.52 million, and is expected to expand at approximately 9.0% CAGR through 2032. Its market leadership is closely linked with the rise of standardized broccoli seed extracts in dietary supplements, powdered nutrition, functional beverages and health-focused formulations. Broccoli seeds offer concentrated glucoraphanin levels and support efficient water-based extraction, allowing manufacturers to supply reproducible ingredient grades at commercial scale. TrueBroc® represents an established example of broccoli-seed-derived glucoraphanin positioned for nutritional supplements, foods and beverages. EXTRABROC® currently offers a 14.5% glucoraphanin extract with stated annual production capacity of 50 tonnes, while other suppliers market 13–30% glucoraphanin products for international nutraceutical manufacturing. Sinigrin represented approximately 22.0% of the market in 2025, equivalent to USD 24.64 million. Its commercial base is centered on black and brown mustard, where sinigrin forms the predominant glucosinolate. Nigrin® provides a clear example of this commercial pathway through a Brassica nigra extract standardized to 25% glucosinolate, compared with naturally occurring sinigrin concentrations of roughly 2–3% in conventional black mustard material. Glucobrassicin and other indole glucosinolates contributed approximately 6.2% of market revenue, or USD 6.94 million, followed by glucoerucin at 4.0% and USD 4.48 million, and gluconasturtiin at approximately 3.1% and USD 3.47 million. Other specialized glucosinolates represented around 6.2%, reflecting demand across botanical ingredients, analytical standards and emerging formulation platforms. Broccoli Accounts for More Than 60% of Glucosinolate Revenue by Source Broccoli-derived ingredients generated approximately USD 67.65 million in 2025 and represented 60.4% of global market revenue. The segment benefits from concentrated glucoraphanin content in broccoli seeds, established extraction expertise and broad formulation compatibility across capsules, tablets, powders, drinks and functional nutrition. Mustard-derived glucosinolates accounted for approximately 21.3% or USD 23.86 million, supported primarily by sinigrin-rich standardized extracts. Rapeseed and canola represented approximately 6.5% or USD 7.28 million, while radish, watercress and other Brassicaceae sources generated approximately USD 10.42 million, equivalent to 9.3% of global revenue. Purified, biotechnology-assisted and source-independent specialty products contributed the remaining 2.5%, or approximately USD 2.80 million. Ingredient economics increasingly reward crops with predictable phytochemical profiles. Agricultural practices that elevate glucosinolate concentration can increase the active yield available for downstream extraction. In September 2026, researchers identified 13 glucosinolates in kale sprouts and demonstrated that methyl jasmonate treatment significantly increased major compounds including sinigrin, glucoraphanin and glucobrassicin, highlighting a pathway for higher-value glucosinolate-rich biomass. Standardized Botanical Extracts Form the Commercial Core of the Market Standardized botanical extracts represented approximately 82.0% of total market revenue in 2025, generating USD 91.84 million. These ingredients carry defined concentrations of glucoraphanin, sinigrin or total glucosinolates and serve as the primary commercial form used by supplement brands, functional-food developers and ingredient formulators. Broccoli seed extracts demonstrate the range of specifications available in the market. Commercial portfolios offer glucoraphanin grades around 0.6%, 1%, 2%, 10%, 13%, 22% and 30%, while dedicated 13% material is commonly available in 25 kg industrial packaging. One supplier currently states monthly production capacity of approximately 2,000 kg, while another specialist supplier reports 50 tonnes of annual capacity for a 14.5% glucoraphanin product. Glucosinolate-rich concentrates and specialty meals represented approximately 11.0% of 2025 revenue, equal to USD 12.32 million, with demand across agricultural, specialty feed and functional-processing applications. Purified and isolated glucosinolates contributed approximately 7.0%, or USD 7.84 million. Their market operates at exceptionally low physical volumes and high unit values because analytical-grade products are frequently supplied in milligram- or gram-scale quantities. Dietary Supplements and Nutraceuticals Generate 56% of Market Revenue Dietary supplements and nutraceuticals represented approximately 56.0% of the Glucosinolates Market in 2025, generating USD 62.72 million. Standardized glucoraphanin-rich broccoli extract forms the largest ingredient category within this application, supported by capsules, tablets, powder blends, gummies and increasingly sophisticated formulations combining glucoraphanin with myrosinase. A February 2026 randomized clinical study demonstrated the commercial importance of this formulation approach. Glucoraphanin-rich broccoli seed extract paired with mustard-seed-derived myrosinase achieved average sulforaphane bioavailability of 39.8%, compared with 18.6% from glucoraphanin-rich extract alone. Conversion during the first eight hours reached approximately 25.4% versus 8.0%, reinforcing interest in glucoraphanin-plus-myrosinase systems for higher-efficiency supplement formulations. Functional foods, beverages and medical nutrition accounted for approximately 16.0% of the market, equivalent to USD 17.92 million. Water-dispersible glucoraphanin ingredients expand formulation possibilities across powdered beverages, tea, coffee, shots, sports nutrition and medical nutrition. Current commercial ingredient platforms specifically target beverages, powder blends, dietary supplements, foods for special medical purposes and sports-nutrition products. Pharmaceutical, biomedical and analytical applications generated approximately USD 12.32 million and 11.0% of global revenue. This segment encompasses purified research compounds, analytical standards and glucosinolate materials used in biochemical and clinical studies. Agriculture and biofumigation represented approximately 7.0% or USD 7.84 million, supported by the ability of glucosinolate-rich Brassica materials to generate functional isothiocyanates. Cosmetics and personal care generated around USD 5.60 million and 5.0%, animal nutrition contributed approximately USD 3.36 million and 3.0%, and food-preservation and other specialty applications represented approximately USD 2.24 million and 2.0%. Assay Strength Creates a Wide Commercial Pricing Spectrum Glucosinolate pricing is closely linked with active concentration. Commercial value rises as processors move from broad Brassica concentrates toward assay-defined glucoraphanin or sinigrin ingredients. Botanical source, extraction yield, HPLC verification, ingredient stability, packaging size and order quantity create additional pricing differentiation. The global market's approximately USD 112.0 million in 2025 revenue and 780 metric tonnes of sales imply an effective blended value of around USD 143 per kg. Standardized botanical extracts carried an effective commercial value around USD 185 per kg, while glucosinolate-rich concentrates and specialty meals averaged closer to USD 45 per kg. High-purity analytical compounds contribute revenue from extremely small physical quantities and therefore carry a much higher value per kilogram. Commercial evidence supports this concentration-sensitive pricing structure. A current 13% glucoraphanin broccoli extract listing shows a commercial price range of approximately USD 135–282 per kg with a 25 kg minimum order quantity, illustrating how assay and order volume influence procurement economics. The approximately 780 metric tonnes of commercial ingredient sold in 2025 represent roughly 70 metric tonnes of active-glucosinolate equivalent after adjustment for typical ingredient assays. This provides a useful secondary measure of functional material entering the market while commercial ingredient tonnage remains the primary volume indicator. North America Leads Revenue as Asia Pacific Accelerates North America held approximately 34.5% of global Glucosinolates Market revenue in 2025, equivalent to USD 38.64 million. The region benefits from a developed dietary-supplement industry, established branded glucoraphanin ingredients, significant clinical activity and premium standardized formulations. Asia Pacific accounted for approximately 32.5%, or USD 36.40 million, and is projected to register the fastest regional CAGR of around 8.8% through 2032. China combines large botanical-processing capacity with expanding functional-nutrition demand, while Japan and South Korea support higher-value formulations. India brings a strong botanical extraction base, mustard availability and growing nutraceutical production capability. Europe represented approximately 27.0% of global market revenue in 2025, or USD 30.24 million, led by Germany, the United Kingdom, France and Italy. Latin America generated approximately USD 3.92 million and 3.5%, while the Middle East and Africa represented approximately USD 2.80 million and 2.5%. United States Represents the Largest National Market The United States generated approximately USD 33.60 million in 2025, representing 30.0% of global revenue, with commercial glucosinolate ingredient demand of approximately 204 metric tonnes. Premium glucoraphanin, standardized nutraceutical extracts and higher-value formulation systems lift its revenue share above its physical-volume share. China represented approximately 10.5% of global revenue, or USD 11.76 million, alongside approximately 107 metric tonnes of ingredient consumption. Japan generated approximately USD 8.40 million, followed by Germany at USD 7.28 million, the United Kingdom at USD 5.60 million, South Korea at USD 5.38 million and Canada at USD 5.04 million. India accounted for approximately USD 4.48 million and 4.0% of market revenue, while its physical demand reached around 47 metric tonnes. India is projected to expand at approximately 10.0% CAGR through 2032, supported by standardized botanical manufacturing, mustard-derived ingredients and growing domestic and export-focused nutraceutical production. France generated approximately USD 4.26 million, Italy USD 3.70 million, Australia USD 2.91 million, Brazil USD 2.46 million and Spain USD 2.46 million. Glucosinolate Supply Chains Are Moving Toward Higher Standardization The commercial value chain starts with glucosinolate-rich Brassicaceae crops and progresses through raw-material selection, extraction, concentration, HPLC standardization, stability control and formulation support. Ingredient manufacturers increasingly integrate seed sourcing with analytical quality systems to maintain predictable active concentrations across production batches. Broccoli seed occupies the premium end of the supply chain. Commercial products currently include 13% glucoraphanin powders supplied in 25 kg drums, 14.5% standardized material produced at tens-of-tonnes scale, and higher-assay grades approaching 30%. Mustard follows a complementary route focused on sinigrin concentration and controlled conversion to allyl isothiocyanate. Formulation innovation is also moving closer to the enzymatic stage. Pairing glucoraphanin with standardized myrosinase provides manufacturers with a more controlled route to sulforaphane formation. In 2026, 4POTENTIA® introduced OptiBroc®, a broccoli seed extract standardized to at least 13% glucoraphanin, alongside MyZyme™, a standardized myrosinase ingredient designed to support sulforaphane formation. Direct Sulforaphane and Enzyme-Controlled Conversion Shape Future Competition Glucosinolate innovation is moving in two parallel directions. The first emphasizes higher-purity and more stable precursors such as glucoraphanin. The second focuses on improving the efficiency with which glucosinolates form downstream isothiocyanates. Sulforaphane-focused technologies represent the strongest competitive pressure for glucoraphanin-rich ingredients because glucoraphanin's commercial functionality is closely connected with its conversion to sulforaphane. Greater sulforaphane stability and advanced delivery technologies can shift value toward downstream formulations, while glucoraphanin suppliers can reinforce their position through stable precursors, traceable botanical sourcing and reliable myrosinase systems. Sinigrin follows a comparable pathway through allyl isothiocyanate. Advances in controlled hydrolysis, microbial conversion and encapsulation can expand the functionality of mustard-derived glucosinolates across nutrition, food and agricultural applications. Fermentation creates another growth pathway. Temperature-managed microbial systems can substantially raise the conversion of glucosinolates into sulforaphane, broadening the opportunity for fermented Brassica ingredients and precision functional-food products. Recent Developments in the Glucosinolates Market In 2026, researchers reported in Nature Plants that CRISPR-based modification of pennycress reduced seed glucosinolate content by approximately 75% through targeted mutations involving MYB28/HAG1 and MYC3 transcription factors. The development demonstrates the growing use of genome engineering to control glucosinolate levels in oilseed crops, with direct implications for crop quality, feed suitability, and commercial breeding programs. In April 2025, research presented at the American Association for Cancer Research Annual Meeting evaluated the glucosinolate-derived compounds indole-3-carbinol and sulforaphane across human cancer cell lines. Indole-3-carbinol showed differential growth-inhibitory activity among tumor types, while sulforaphane produced gene-expression signatures linked with antioxidant and antiproliferative pathways, supporting further development of glucosinolate derivatives for nutraceutical and pharmaceutical research applications. Research Methodology Strategic Market Research evaluates the Glucosinolates Market through the commercial movement of standardized botanical extracts, glucosinolate-rich specialty ingredients and purified glucosinolate compounds. Market assessment begins with botanical source, principal glucosinolate, assay concentration, commercial packaging, production capability, application profile and realized business-to-business ingredient pricing. Commercial volumes are established from standardized extract supply, disclosed manufacturing capacity, supplier shipment formats and downstream formulation requirements. Different assay strengths are normalized to active-glucosinolate equivalents, creating consistency between a 5% glucoraphanin powder, a 13–14.5% standardized broccoli extract and a 25% glucosinolate mustard ingredient. Revenue assessment combines ingredient tonnage with concentration-specific commercial pricing and reconciles the resulting values against nutraceutical dosage patterns, functional-food formulations, agricultural usage and analytical demand. Geographic allocation reflects ingredient consumption and formulation activity in each country, while manufacturing location and export flows are assessed independently. Forecast assumptions incorporate growth in standardized nutraceutical ingredients, increased adoption of glucoraphanin-myrosinase systems, higher assay concentrations, functional-food expansion, Asian botanical processing, scientific activity around glucoraphanin and sinigrin, and growing conversion efficiency through fermentation and controlled processing. These factors support the progression from USD 112.0 million in 2025 to approximately USD 194.4 million by 2032, alongside commercial ingredient volume growth from approximately 780 metric tonnes to 1,290 metric tonnes. Report Coverage Table Report Attribute Details Forecast Period 2026 – 2032 Market Size Value in 2025 USD 112.0 Million Revenue Forecast in 2032 USD 194.4 Million Overall Growth Rate CAGR of 8.2% (2026 – 2032) Base Year for Estimation 2025 Historical Data 2019 – 2024 Unit USD Million, Metric Tonnes, CAGR (2026 – 2032) Segmentation By Principal Glucosinolate, By Source, By Product Form, By Application, By Geography By Principal Glucosinolate Glucoraphanin, Sinigrin, Glucobrassicin & Other Indole Glucosinolates, Glucoerucin, Gluconasturtiin, Other Glucosinolates By Source Broccoli, Mustard, Rapeseed/Canola, Radish, Watercress & Other Brassicaceae, Synthetic/Biotechnological & Source-Unspecified Purified Products By Product Form Standardized Botanical Extracts, Purified/Isolated Glucosinolates, Glucosinolate-Rich Concentrates & Specialty Meals By Application Dietary Supplements & Nutraceuticals, Functional Foods, Beverages & Medical Nutrition, Pharmaceutical, Biomedical Research & Analytical Applications, Agriculture & Biofumigation, Cosmetics & Personal Care, Animal Nutrition & Feed, Food Preservation & Other Specialty Applications By Region North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Country Scope U.S., Canada, Mexico, China, India, Japan, South Korea, Australia, Germany, UK, France, Italy, Spain, Netherlands, Switzerland, Brazil, Argentina, GCC Countries, South Africa Market Volume in 2025 Approximately 780 Metric Tonnes Market Volume Forecast in 2032 Approximately 1,290 Metric Tonnes Key Market Drivers Growing use of standardized glucoraphanin ingredients, rising demand for dietary supplements and nutraceuticals, increasing adoption of glucoraphanin-myrosinase formulations, expansion of functional foods and beverages, higher demand for high-assay botanical extracts, and growth of Asian botanical ingredient manufacturing Customization Option Available upon request Frequently Asked Question About This Report Q1. What is the size and growth outlook of the global Glucosinolates Market? A1. The global Glucosinolates Market was valued at approximately USD 112.0 million in 2025 and is projected to reach around USD 194.4 million by 2032. The market is expected to grow at a CAGR of approximately 8.2% during 2026–2032. Q2. How much glucosinolate ingredient is sold globally each year? A2. Global commercial glucosinolate ingredient sales reached approximately 780 metric tonnes in 2025. Sales volume is projected to approach 1,290 metric tonnes by 2032 as standardized botanical extracts gain wider use in supplements, functional nutrition, research, and specialty applications. Q3. Which glucosinolate holds the largest market share? A3. Glucoraphanin holds the largest share of the global market. It generated approximately USD 65.52 million in 2025, accounting for about 58.5% of total revenue, supported by strong demand for standardized broccoli seed extracts used in nutraceutical and functional nutrition products. Q4. Which source accounts for the largest share of the Glucosinolates Market? A4. Broccoli is the leading source of commercial glucosinolates, generating approximately USD 67.65 million in 2025 and accounting for about 60.4% of global revenue. Its leadership is mainly supported by high-value glucoraphanin-rich broccoli seed extracts. Q5. Which application consumes the most glucosinolates? A5. Dietary supplements and nutraceuticals are the largest application, accounting for approximately 56.0% of global revenue in 2025, equal to around USD 62.72 million. Functional foods, beverages, and medical nutrition represented a further 16.0% of the market. Q6. Which countries represent the largest Glucosinolates Markets? A6. The United States was the largest country market with approximately USD 33.60 million in 2025 revenue, followed by China at USD 11.76 million and Japan at USD 8.40 million. Germany generated approximately USD 7.28 million, while the United Kingdom and South Korea accounted for around USD 5.60 million and USD 5.38 million, respectively. Sources: Brassica Protection Products / TrueBroc® – Commercial glucoraphanin ingredient information Arjuna Natural – Nigrin® 25% glucosinolate black mustard extract EXTRABROC® – 14.5% glucoraphanin broccoli extract and annual capacity Kintai – Commercial broccoli seed extract specifications and production capacity 4POTENTIA® – OptiBroc® standardized glucoraphanin ingredient Scientific Reports – Glucoraphanin and mustard myrosinase randomized clinical study, 2026 Physiologia Plantarum – Glucosinolate accumulation in kale sprouts, 2026 Food Research International – Broccoli glucosinolate bioconversion through fermentation, 2026 Food Chemistry: X – Glucoraphanin hydrolysis and magnetic-field-assisted processing, 2026 Tokyo Chemical Industry – High-purity sinigrin reference material Table of Contents - Global Glucosinolates Market Report (2026–2032) Executive Summary Market Overview Market Attractiveness by Principal Glucosinolate, Source, Product Form, Application, and Region Strategic Insights from Key Executives (CXO Perspective) Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Sales Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Active Glucosinolate Equivalent Volume Analysis Summary of Market Segmentation by Principal Glucosinolate, Source, Product Form, Application, and Region Market Share Analysis Leading Players by Commercial Presence and Market Position Market Share Analysis by Principal Glucosinolate Market Share Analysis by Source Market Share Analysis by Product Form Market Share Analysis by Application Regional and Country-Level Revenue Share Analysis Investment Opportunities in the Glucosinolates Market Key Developments in Standardized Glucosinolate Ingredients Innovation in Glucoraphanin and Myrosinase Formulations Investment Opportunities in High-Assay Broccoli Seed Extracts Growth Opportunities in Sinigrin-Rich Mustard Extracts Expansion Opportunities in Functional Foods, Beverages, and Medical Nutrition Opportunities in Purified Glucosinolates for Biomedical and Analytical Applications Emerging Opportunities in Fermentation-Assisted Glucosinolate Conversion High-Growth Country Opportunities across the United States, China, India, Japan, and South Korea Market Introduction Definition and Scope of the Study Commercial Importance of Glucosinolates Glucosinolate-Myrosinase Conversion Pathway Role of Glucoraphanin, Sinigrin, Glucobrassicin, Glucoerucin, and Gluconasturtiin Market Structure and Key Findings Overview of Top Investment Pockets Commercial Shift toward Standardized and Higher-Assay Ingredients Research Methodology Research Process Overview Primary and Secondary Research Approaches Supplier Portfolio and Commercial Product Assessment Glucosinolate Assay and Concentration Normalization Commercial Sales Volume Estimation in Metric Tonnes Active Glucosinolate Equivalent Volume Estimation Business-to-Business Pricing and ASP Assessment Production Capacity and Supply Availability Validation Downstream Formulation and Application Demand Assessment Country-Level Revenue and Volume Allocation Data Triangulation and Segment-Level Forecasting Approach Market Dynamics Growing Demand for Standardized Glucoraphanin Ingredients Expansion of Dietary Supplement and Nutraceutical Applications Growth of Functional Foods, Beverages, and Medical Nutrition Increasing Use of Glucoraphanin-Myrosinase Formulations Rising Commercial Value of Higher-Assay Broccoli Seed Extracts Growth of Sinigrin-Rich Mustard Ingredients Role of Botanical Source, Purity, Assay Strength, and Batch Consistency in Pricing Advances in Fermentation and Enzyme-Assisted Glucosinolate Conversion Expansion of Asian Botanical Extraction and Ingredient Manufacturing Growth Opportunities in Agriculture, Biofumigation, and Specialty Applications Competitive Impact of Stabilized Sulforaphane and Direct Isothiocyanates Ingredient Standardization, Traceability, and Quality-Control Trends Global Glucosinolates Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Sales Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Commercial Ingredient Volume and Active Glucosinolate Equivalent Analysis Average Selling Price and Assay-Based Pricing Analysis Market Analysis by Principal Glucosinolate: Glucoraphanin Sinigrin Glucobrassicin & Other Indole Glucosinolates Glucoerucin Gluconasturtiin Other Glucosinolates Market Analysis by Source: Broccoli Mustard Rapeseed/Canola Radish, Watercress & Other Brassicaceae Synthetic/Biotechnological & Source-Unspecified Purified Products Market Analysis by Product Form: Standardized Botanical Extracts Purified/Isolated Glucosinolates Glucosinolate-Rich Concentrates & Specialty Meals Market Analysis by Application: Dietary Supplements & Nutraceuticals Functional Foods, Beverages & Medical Nutrition Pharmaceutical, Biomedical Research & Analytical Applications Agriculture & Biofumigation Cosmetics & Personal Care Animal Nutrition & Feed Food Preservation & Other Specialty Applications Market Analysis by Region: North America Europe Asia-Pacific Latin America Middle East & Africa Glucosinolates Pricing and Commercial Volume Analysis Global Commercial Sales Volume Analysis Active Glucosinolate Equivalent Volume Analysis Pricing Analysis by Glucoraphanin Concentration Pricing Analysis of Sinigrin-Rich Mustard Extracts Pricing of Purified and Analytical-Grade Glucosinolates Impact of Assay Strength on Commercial Selling Prices Impact of Packaging Size and Order Volume on Pricing Revenue Growth versus Physical Volume Growth Glucosinolates Supply Chain and Value Chain Analysis Broccoli Seed and Brassicaceae Raw Material Supply Mustard Seed and Sinigrin-Rich Raw Material Supply Extraction, Concentration, and Standardization HPLC Testing and Active-Content Verification Bulk Ingredient Packaging and Distribution Nutraceutical and Functional-Food Formulation Research and Analytical-Grade Distribution International Trade and Cross-Border Ingredient Supply Regional Market Analysis North America Glucosinolates Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Principal Glucosinolate, Source, Product Form, and Application Glucoraphanin and Nutraceutical Demand Analysis Country-Level Breakdown: United States Canada Mexico Europe Glucosinolates Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Principal Glucosinolate, Source, Product Form, and Application Functional Nutrition and Standardized Botanical Extract Demand Country-Level Breakdown: Germany United Kingdom France Italy Spain Netherlands Switzerland Rest of Europe Asia-Pacific Glucosinolates Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Principal Glucosinolate, Source, Product Form, and Application Botanical Extraction Capacity and Standardized Ingredient Production Country-Level Breakdown: China India Japan South Korea Australia Rest of Asia-Pacific Latin America Glucosinolates Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Principal Glucosinolate, Source, Product Form, and Application Country-Level Breakdown: Brazil Argentina Rest of Latin America Middle East & Africa Glucosinolates Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size and Commercial Volume Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Principal Glucosinolate, Source, Product Form, and Application Country-Level Breakdown: GCC Countries South Africa Rest of Middle East & Africa Technology, Formulation, and Ingredient Innovation Higher-Assay Glucoraphanin Extract Development Glucoraphanin-Myrosinase Combination Formulations Fermentation-Assisted Glucosinolate Conversion Processing Technologies for Improved Myrosinase Activity Water-Dispersible Glucosinolate Ingredients Stability and Shelf-Life Improvement Analytical Standardization and HPLC-Based Quality Control Substitution and Competitive Technology Analysis Stabilized Sulforaphane as an Alternative to Glucoraphanin-Based Systems Direct Allyl Isothiocyanate as an Alternative to Sinigrin Conversion Whole Broccoli Sprout and Brassica Concentrates Fermentation-Based Sulforaphane Production Alternative Natural Food-Preservation Ingredients Alternative Agricultural Biofumigation Technologies Impact of Substitute Technologies on Future Glucosinolate Demand Competitive Intelligence and Benchmarking Leading Market Participants and Glucosinolate Ingredient Suppliers: Brassica Protection Products LLC Arjuna Natural Pvt. Ltd. 4POTENTIA EXTRABROC Kintai Biological Technology Co., Ltd. Shanghai Everivy Biotech Co., Ltd. Yunnan Jiuzhen Biotechnology Co., Ltd. Tokyo Chemical Industry Co., Ltd. Merck KGaA / Sigma-Aldrich Competitive Landscape and Strategic Positioning Benchmarking by Glucosinolate Type and Assay Strength Benchmarking by Botanical Source and Extraction Capability Glucoraphanin Product Portfolio Comparison Sinigrin and Mustard-Derived Ingredient Positioning Production Capacity and Commercial Scale Benchmarking Purity, HPLC Verification, and Quality-Control Benchmarking Myrosinase Compatibility and Conversion-Efficiency Positioning Regional Manufacturing and Distribution Presence Product Launches, Partnerships, and Commercial Developments Recent Developments in the Glucosinolates Market 2026 Product Launches and Commercial Ingredient Developments 2026 Glucoraphanin and Myrosinase Formulation Developments 2026 Glucosinolate Extraction and Processing Innovations 2026 Fermentation and Bioconversion Developments 2026 Agricultural and Raw-Material Enhancement Developments Strategic Partnerships, Capacity Expansion, and Market Entry Activity Appendix Abbreviations and Terminologies Used in the Report Glucosinolate Compound and Botanical Source Mapping Commercial Assay and Concentration Definitions References and Sources List of Tables Global Glucosinolates Market Size and Volume (2019–2032) Market Size by Principal Glucosinolate (2026–2032) Market Size by Source (2026–2032) Market Size by Product Form (2026–2032) Market Size by Application (2026–2032) Regional Glucosinolates Market Size and Volume (2026–2032) Country-Level Revenue and Commercial Volume Analysis Glucoraphanin Concentration and Commercial Pricing Analysis Commercial Ingredient Volume versus Active Glucosinolate Equivalent Volume Competitive Benchmarking of Leading Glucosinolate Ingredient Suppliers Glucosinolate Technology and Substitute Benchmarking List of Figures Global Glucosinolates Market Size and Growth Outlook (2025–2032) Global Glucosinolates Commercial Sales Volume Outlook Market Share by Principal Glucosinolate (2025 vs. 2032) Market Share by Source (2025 vs. 2032) Market Share by Product Form (2025 vs. 2032) Market Share by Application (2025 vs. 2032) Regional Glucosinolates Market Snapshot Country-Level Glucosinolates Revenue Comparison Glucosinolate-Myrosinase Conversion Pathway Glucosinolates Supply Chain and Value Chain Assay Strength and Commercial Pricing Relationship Glucoraphanin, Sinigrin, and Other Major Glucosinolate Commercial Positioning Competitive Landscape by Commercial Presence Growth Strategies Adopted by Key Market Participants Glucosinolates Market Drivers, Opportunities, Technology Trends, and Substitution Landscape